FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030463003> ?p ?o ?g. }

• W2030463003 endingPage "234" @default.
• W2030463003 startingPage "231" @default.
• W2030463003 abstract "The ErbB2 receptor is a proto-oncogene associated with a poor prognosis in breast cancer. Trastuzumab, a humanized anti-ErbB2 antibody currently in clinical use, has proven to be an essential tool in the immunotherapy of breast carcinoma. Additionally, ErbB2 is involved in the growth and survival pathway of adult cardiomyocytes which accounts for the trastuzumab-induced cardiotoxicity. Moreover, in metastatic breast cancer patients treated with trastuzumab, endomyocardial biopsy documented focal vacuolar changes, pleomorphic mitochondria, myocardial cell hypertrophy, and mild interstitial fibrosis on electron microscopy without accompanying light microscopic abnormalities, a finding consistent with a reversible pattern of cardiac injury. On the other hand, aldosterone and mineralocorticoid receptor (MR) researches have experienced a revival after the discovery that aldosterone and MR are not only involved in the electrolyte and volume balance but also in the pathophysiological processes of the reno-cardiovascular system. Aldosterone has both genomic and nongenotropic effects on epidermal growth factor receptor (EGFR) expression. Genomic effect induces genomic up-regulation of the EGFR protein expression via EGFR promoter, whereas nongenotropic effect leads to the EGFR transactivation resulting in persistent pathophysiological effects including formation of extracellular matrix and myocardial hypertrophy. Spironolactone, an aldosterone receptor antagonist, is known to ameliorate the cardiac damage. The underlying mechanism for the genomic interactions seem to be the stimulation of the EGFR promoter by aldosterone-bound MR, which then dose-dependently enhances the EGFR protein levels, which may be successively inhibited by spironolactone. By the light of these findings, we hypothesize that spironolactone may ameliorate trastuzumab-induced cardiotoxicity via inhibition of transactivation of the EGFR by aldosterone and reversing myocardial hypertrophy. This issue warrants further studies." @default.
• W2030463003 created "2016-06-24" @default.
• W2030463003 creator A5030466196 @default.
• W2030463003 creator A5060193570 @default.
• W2030463003 creator A5065115743 @default.
• W2030463003 creator A5067017471 @default.
• W2030463003 creator A5070958553 @default.
• W2030463003 date "2013-08-01" @default.
• W2030463003 modified "2023-10-16" @default.
• W2030463003 title "Does spironolactone ameliorate trastuzumab-induced cardiac toxicity?" @default.
• W2030463003 cites W1998028009 @default.
• W2030463003 cites W2006236410 @default.
• W2030463003 cites W2035708557 @default.
• W2030463003 cites W2045324973 @default.
• W2030463003 cites W2048686497 @default.
• W2030463003 cites W2050674912 @default.
• W2030463003 cites W2062304390 @default.
• W2030463003 cites W2068061415 @default.
• W2030463003 cites W2085250186 @default.
• W2030463003 cites W2099545363 @default.
• W2030463003 cites W2106287154 @default.
• W2030463003 cites W2107427447 @default.
• W2030463003 cites W2115759102 @default.
• W2030463003 cites W2122472092 @default.
• W2030463003 cites W2133105825 @default.
• W2030463003 cites W2134533989 @default.
• W2030463003 cites W2142681531 @default.
• W2030463003 cites W2144124503 @default.
• W2030463003 cites W2144848856 @default.
• W2030463003 cites W2146384083 @default.
• W2030463003 cites W2147529602 @default.
• W2030463003 cites W2152338271 @default.
• W2030463003 cites W2160329331 @default.
• W2030463003 cites W2170105378 @default.
• W2030463003 cites W2278310587 @default.
• W2030463003 cites W2278572564 @default.
• W2030463003 cites W2312647513 @default.
• W2030463003 cites W2318605753 @default.
• W2030463003 cites W2335620420 @default.
• W2030463003 cites W4232995978 @default.
• W2030463003 cites W4233498657 @default.
• W2030463003 cites W4239462698 @default.
• W2030463003 cites W4255532144 @default.
• W2030463003 doi "https://doi.org/10.1016/j.mehy.2013.04.042" @default.
• W2030463003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23688742" @default.
• W2030463003 hasPublicationYear "2013" @default.
• W2030463003 type Work @default.
• W2030463003 sameAs 2030463003 @default.
• W2030463003 citedByCount "7" @default.
• W2030463003 countsByYear W20304630032014 @default.
• W2030463003 countsByYear W20304630032016 @default.
• W2030463003 countsByYear W20304630032017 @default.
• W2030463003 countsByYear W20304630032019 @default.
• W2030463003 countsByYear W20304630032021 @default.
• W2030463003 countsByYear W20304630032022 @default.
• W2030463003 crossrefType "journal-article" @default.
• W2030463003 hasAuthorship W2030463003A5030466196 @default.
• W2030463003 hasAuthorship W2030463003A5060193570 @default.
• W2030463003 hasAuthorship W2030463003A5065115743 @default.
• W2030463003 hasAuthorship W2030463003A5067017471 @default.
• W2030463003 hasAuthorship W2030463003A5070958553 @default.
• W2030463003 hasConcept C121608353 @default.
• W2030463003 hasConcept C126322002 @default.
• W2030463003 hasConcept C134018914 @default.
• W2030463003 hasConcept C189135053 @default.
• W2030463003 hasConcept C2776379505 @default.
• W2030463003 hasConcept C2778233292 @default.
• W2030463003 hasConcept C2778525890 @default.
• W2030463003 hasConcept C2779438470 @default.
• W2030463003 hasConcept C2779786085 @default.
• W2030463003 hasConcept C29730261 @default.
• W2030463003 hasConcept C502942594 @default.
• W2030463003 hasConcept C530470458 @default.
• W2030463003 hasConcept C71924100 @default.
• W2030463003 hasConceptScore W2030463003C121608353 @default.
• W2030463003 hasConceptScore W2030463003C126322002 @default.
• W2030463003 hasConceptScore W2030463003C134018914 @default.
• W2030463003 hasConceptScore W2030463003C189135053 @default.
• W2030463003 hasConceptScore W2030463003C2776379505 @default.
• W2030463003 hasConceptScore W2030463003C2778233292 @default.
• W2030463003 hasConceptScore W2030463003C2778525890 @default.
• W2030463003 hasConceptScore W2030463003C2779438470 @default.
• W2030463003 hasConceptScore W2030463003C2779786085 @default.
• W2030463003 hasConceptScore W2030463003C29730261 @default.
• W2030463003 hasConceptScore W2030463003C502942594 @default.
• W2030463003 hasConceptScore W2030463003C530470458 @default.
• W2030463003 hasConceptScore W2030463003C71924100 @default.
• W2030463003 hasIssue "2" @default.
• W2030463003 hasLocation W20304630031 @default.
• W2030463003 hasLocation W20304630032 @default.
• W2030463003 hasOpenAccess W2030463003 @default.
• W2030463003 hasPrimaryLocation W20304630031 @default.
• W2030463003 hasRelatedWork W1971595373 @default.
• W2030463003 hasRelatedWork W1980583333 @default.
• W2030463003 hasRelatedWork W2019725123 @default.
• W2030463003 hasRelatedWork W2037408526 @default.
• W2030463003 hasRelatedWork W2072829430 @default.
• W2030463003 hasRelatedWork W2312942238 @default.

• next